TREATMENT OF CANCER BY TARGETING MOLECULES THAT INFLUENCE MST1/STK4 SIGNALING

• 收藏
• 分享

专利权人:

Bekir Cinar

发明人:

Bekir Cinar,Filiz Kisaayak Collak

申请号：

US13415711

公开号：

US20120238562A1

申请日:

2012.03.08

申请国别(地区):

US

年份:

2012

代理人:

摘要：

The invention relates to the treatment of prostate cancer. In various embodiments, the invention teaches a method of administering one or more compounds that inhibit a molecule that antagonizes the activity of tumor suppressor Mst1 and Mst2 pathway signaling. In certain embodiments, one or more of the compounds include an mTOR and PI3K inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/